Description

LuciTirze 5mg Injection (Tirzepatide) – Uses, Side Effects, Dosage & Price in Pakistan

LuciTirze 5mg Injection (Tirzepatide) is a prescription injectable medicine containing tirzepatide, a dual GIP and GLP-1 receptor agonist. Tirzepatide is used under approved treatment settings to improve blood-sugar control in people with type 2 diabetes. Tirzepatide is also approved under specific product labeling for chronic weight management in eligible patients.

LuciTirze is administered as a subcutaneous injection once weekly. The 5mg strength is an important step in the tirzepatide dosing schedule, but treatment is generally not started directly at 5mg. The usual initiation dose is 2.5mg once weekly for four weeks, followed by an increase to 5mg once weekly.

Tirzepatide can improve glucose control, reduce appetite, and support weight reduction in appropriately selected patients. However, it is a prescription medicine with important precautions and should be used under medical supervision.

Patients searching for LuciTirze 5mg Injection in Pakistan can check current product information, price, and availability through Impo Medic.

LuciTirze 5mg Injection (Tirzepatide) Uses

Tirzepatide has different approved indications depending on the specific product and regulatory jurisdiction.

Type 2 Diabetes

Tirzepatide is used along with diet and exercise to improve blood-glucose control in patients with type 2 diabetes mellitus under approved treatment settings.

It may help reduce fasting and post-meal blood glucose and improve HbA1c.

Tirzepatide is not insulin. However, some patients may receive it together with other diabetes medicines. When it is combined with insulin or medicines that increase insulin secretion, the risk of low blood sugar may increase.

Weight Management

Under specific approved product labeling, tirzepatide is used for long-term weight management in eligible adults with obesity or overweight accompanied by certain weight-related health conditions.

It is intended to be used together with:

• A reduced-calorie diet
• Increased physical activity
• Appropriate medical monitoring

Tirzepatide should not be considered a casual or cosmetic weight-loss injection. A healthcare professional should determine whether treatment is appropriate.

Obstructive Sleep Apnea

Under specific tirzepatide weight-management labeling, the medicine also has an approved role in adults with moderate-to-severe obstructive sleep apnea and obesity.

Not every tirzepatide brand is registered for every indication. Patients should follow the approved indication of the actual product being prescribed.

How Does LuciTirze 5mg Injection Work?

Tirzepatide acts on two hormone receptors:

GIP – glucose-dependent insulinotropic polypeptide receptor

and

GLP-1 – glucagon-like peptide-1 receptor

These hormones are involved in blood-glucose regulation, appetite, and food intake.

When blood glucose is elevated, tirzepatide helps increase insulin secretion. It can also reduce glucagon levels and delay gastric emptying.

Its effects on appetite can reduce food intake, which contributes to weight reduction in many patients.

Because LuciTirze influences several metabolic processes, treatment should be combined with an appropriate medical, nutritional, and lifestyle plan rather than being used without professional supervision.

LuciTirze 5mg Injection Dosage

LuciTirze 5mg Injection is generally not the initial starting dose of tirzepatide.

A commonly established adult titration schedule is:

Weeks 1–4: 2.5mg injected once weekly.

From Week 5: Increase to 5mg once weekly.

If additional treatment effect is required and the medicine is tolerated, the dose may subsequently be increased in 2.5mg increments after at least four weeks on the current dose.

The dose sequence can therefore include:

2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg

The maximum recommended adult dose under established indications is generally 15mg once weekly.

The correct maintenance dose depends on the indication, clinical response, tolerability, and prescribing instructions.

Never increase your dose simply because a higher-strength injection is available.

How to Use LuciTirze 5mg Injection

LuciTirze is administered once weekly as a subcutaneous injection.

Recommended injection areas include:

• Abdomen
• Thigh
• Upper arm

Injection sites should be rotated with each dose.

Tirzepatide can generally be administered with or without food and at any time of day.

Try to use the injection on the same day each week.

If the day of administration needs to be changed, follow your healthcare professional’s instructions and ensure the appropriate interval between doses.

The exact injection technique depends on whether LuciTirze is supplied as a prefilled pen, vial, or another presentation. Follow the instructions supplied with the actual product.

What If You Miss a Dose?

If a tirzepatide dose is missed, current prescribing guidance generally allows the missed dose to be administered as soon as possible within 4 days (96 hours).

If more than four days have passed, skip the missed dose and take the next dose on the regularly scheduled day.

Do not use two doses too close together to compensate for a missed injection.

If you are uncertain about your schedule, contact your doctor or pharmacist.

Common Side Effects of LuciTirze 5mg

Gastrointestinal side effects are particularly common with tirzepatide, especially when treatment begins or the dose is increased.

Common adverse effects can include:

• Nausea
• Diarrhea
• Reduced appetite
• Vomiting
• Constipation
• Indigestion
• Abdominal pain

Some patients may experience other digestive symptoms or injection-site reactions.

The gradual dose-escalation schedule is designed partly to improve gastrointestinal tolerability.

Contact your healthcare professional if symptoms become severe, persistent, or lead to difficulty maintaining adequate fluid intake.

Thyroid C-Cell Tumor Warning

Tirzepatide carries an important warning concerning thyroid C-cell tumors.

Tirzepatide caused thyroid C-cell tumors in animal studies involving rats. It is currently unknown whether tirzepatide causes these tumors, including medullary thyroid carcinoma, in humans.

Tirzepatide is contraindicated in people with:

• A personal history of medullary thyroid carcinoma (MTC)
• A family history of MTC
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Tell your healthcare professional if you develop a lump or swelling in the neck, persistent hoarseness, difficulty swallowing, or difficulty breathing.

Pancreatitis

Acute pancreatitis has been observed with GLP-1 receptor agonists and tirzepatide.

Seek prompt medical attention if you develop severe, persistent abdominal pain, particularly pain that may spread toward the back.

Vomiting may or may not accompany the pain.

If pancreatitis is suspected, the medicine should be stopped and medically evaluated according to your healthcare professional’s instructions.

Hypoglycemia

The risk of low blood sugar (hypoglycemia) can increase when tirzepatide is used with insulin or insulin-secretagogue medicines such as sulfonylureas.

Symptoms can include:

• Sweating
• Trembling
• Hunger
• Weakness
• Dizziness
• Confusion
• Rapid heartbeat

Your healthcare professional may need to adjust the dose of insulin or certain other diabetes medicines when LuciTirze is introduced.

Do not independently reduce or stop prescribed diabetes treatment.

Severe Gastrointestinal Problems

Tirzepatide can cause gastrointestinal adverse reactions that are sometimes severe.

Persistent vomiting or diarrhea may result in dehydration.

Tirzepatide is not recommended in patients with severe gastroparesis under current prescribing information.

Patients with significant pre-existing gastrointestinal disease should discuss their condition with a healthcare professional before starting treatment.

Kidney Problems and Dehydration

Severe nausea, vomiting, or diarrhea can cause substantial fluid loss.

Dehydration can contribute to acute kidney injury, particularly in people who already have kidney problems.

Patients experiencing gastrointestinal reactions that could lead to dehydration may require kidney-function monitoring.

Seek medical advice if you cannot maintain adequate fluid intake or have persistent vomiting or diarrhea.

Gallbladder Problems

Acute gallbladder disease has been reported during tirzepatide treatment.

Possible problems include gallstones and gallbladder inflammation.

Contact your healthcare professional if you develop severe abdominal pain, fever, yellowing of the skin or eyes, or persistent digestive symptoms.

Further investigation may be required if gallbladder disease is suspected.

Diabetic Retinopathy

Patients with type 2 diabetes and a history of diabetic retinopathy should inform their healthcare professional before using tirzepatide.

Rapid improvement in blood-glucose control has sometimes been associated with temporary worsening of diabetic retinopathy.

Appropriate eye monitoring may be recommended for patients with a history of diabetic eye disease.

Report new or sudden changes in vision promptly.

Drug Interactions

Tirzepatide delays gastric emptying and can potentially affect the absorption of medicines taken by mouth.

Tell your doctor about all medicines and supplements you use, especially:

• Insulin
• Sulfonylureas
• Other diabetes medicines
• Oral medicines requiring precise blood concentrations
• Vitamins
• Herbal products

The healthcare professional can determine whether monitoring or treatment adjustment is required.

Oral Contraceptives

Because tirzepatide delays gastric emptying, it may affect the effectiveness of oral hormonal contraceptives, particularly after starting treatment and following dose increases.

Patients using oral hormonal contraception should discuss contraception with their healthcare professional.

A non-oral contraceptive method or an additional barrier method may be recommended for 4 weeks after treatment initiation and for 4 weeks after each dose escalation.

Pregnancy and Breastfeeding

Tirzepatide may cause fetal harm based on animal data and should not be used for weight reduction during pregnancy.

Tell your doctor if you are pregnant, planning pregnancy, or become pregnant during treatment.

Patients using tirzepatide specifically for weight management should discontinue treatment when pregnancy is recognized according to current prescribing guidance.

Breastfeeding patients should discuss the potential benefits and risks with their healthcare professional before using LuciTirze.

Surgery and Anesthesia

Tirzepatide delays gastric emptying.

Pulmonary aspiration has been reported in patients receiving GLP-1 receptor agonists while undergoing procedures involving general anesthesia or deep sedation.

Before any planned surgery or procedure, tell your:

• Surgeon
• Anesthesiologist
• Dentist
• Other healthcare professional

that you are receiving tirzepatide.

Your medical team will determine how treatment should be managed around the procedure.

Storage of LuciTirze 5mg Injection

Follow the storage instructions printed on the original LuciTirze 5mg Injection packaging.

Storage requirements can vary according to the specific product presentation, so do not automatically apply instructions from another tirzepatide brand to LuciTirze.

Protect injectable medicines from inappropriate temperatures and handle them according to the manufacturer’s instructions.

Do not use an injection if:

• It has expired
• Packaging is damaged
• It has been stored incorrectly
• The solution appears abnormal according to the product instructions

Keep the medicine out of the reach of children.

LuciTirze 5mg Injection Price in Pakistan

The LuciTirze 5mg Injection price in Pakistan may vary according to product presentation, pack size, supplier, stock availability, import costs, and market conditions.

Prices of imported and specialist medicines can change, so patients should confirm current pricing rather than relying on an older online listing.

You can check the latest LuciTirze 5mg Injection price and availability in Pakistan through Impo Medic.

When purchasing an injectable medicine, appropriate storage, product authenticity, packaging integrity, expiry date, and correct strength should also be considered.

How to Buy LuciTirze 5mg Injection in Pakistan

Patients looking to buy LuciTirze 5mg Injection in Pakistan can check product availability and purchasing information through Impo Medic.

Before purchasing, verify:

• LuciTirze product name
• Tirzepatide as the active ingredient
• 5mg strength
• Correct dosage form and presentation
• Original packaging
• Batch information
• Expiry date
• Appropriate storage conditions

Patients should have an appropriate prescription and treatment plan.

Do not start at 5mg simply because that strength is available. The usual initiation schedule begins at 2.5mg once weekly before increasing to 5mg.

Why Choose Impo Medic?

Impo Medic provides product information and availability support for patients looking for specialist and imported medicines in Pakistan.

For injectable medicines such as LuciTirze, correct strength, authentic packaging, expiry information, and proper storage are important considerations.

Patients can check LuciTirze 5mg Injection price and availability in Pakistan through Impo Medic, while treatment eligibility, dosage, titration, diabetes management, and adverse-effect monitoring should remain under the supervision of a qualified healthcare professional.

FAQs About LuciTirze 5mg Injection (Tirzepatide)

What is LuciTirze 5mg Injection used for?

Tirzepatide is used under approved indications to improve blood-glucose control in type 2 diabetes. Specific tirzepatide products are also approved for chronic weight management in eligible patients.

Is LuciTirze 5mg used for weight loss?

Tirzepatide has approved weight-management indications under specific product labeling for eligible patients with obesity or overweight plus certain related conditions. It should be used with appropriate diet, physical activity, and medical supervision.

Is 5mg the starting dose of tirzepatide?

No. Tirzepatide treatment is generally initiated with 2.5mg once weekly for four weeks, followed by an increase to 5mg once weekly.

How often is LuciTirze 5mg used?

Tirzepatide is generally injected once every week, not daily.

Can LuciTirze be taken with food?

The injection can generally be administered at any time of day, with or without meals.

Where should LuciTirze be injected?

Tirzepatide is administered subcutaneously in the abdomen, thigh, or upper arm according to the product instructions.

Can LuciTirze cause low blood sugar?

Tirzepatide can increase the risk of hypoglycemia, particularly when combined with insulin or insulin-secretagogue medicines such as sulfonylureas.

Who should not use tirzepatide?

Tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma, MEN 2, or serious hypersensitivity to tirzepatide or relevant product ingredients.

Where can I check LuciTirze 5mg price in Pakistan?

You can check the current LuciTirze 5mg Injection price and availability in Pakistan through Impo Medic. Confirm current stock and pricing at the time of purchase.